CDKN2A and nasopharyngeal carcinoma: Similar to previous studies, Tian et al. (2013) also investigated promoter methylation of DLEC1, as well as combination with RASSF1A, CDKN2A, DAPK, and UCHL1 as the methylation markers in the diagnosis of NPC in serum samples [38].